Business
Israeli generic drugmaker Teva has bid to purchase rival Mylan, which is headquartered in the Netherlands, for $40 billion. The offer was made as...
Hi, what are you looking for?
Israeli generic drugmaker Teva has bid to purchase rival Mylan, which is headquartered in the Netherlands, for $40 billion. The offer was made as...